14 days of Premium, free.
Every scanner with live hit rates + the Market Pulse risk flag that tells you when to get defensive. No card required.
Start trial →
Tradestie Institutional Equity Comparison Engine · Market Close Nov 17, 2026
EHTH vs IRTC: Which Stock Is the Better Buy Now?
Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.
As of Nov 17, 2026, eHealth, Inc. (EHTH) is the stronger overall head-to-head candidate over iRhythm Technologies, Inc (IRTC) in the Tradestie Institutional Equity Comparison Engine, winning 5–5 core matrix metrics and 4–2 across our 6-pillar institutional scorecard (led by Valuation Multiples, Profitability & Quality, Balance Sheet & Cash Flow). EHTH carries a Unified Composite Score of 40.8/100 (SELL) at $0.35 (0.2x Forward P/E, 11.9% operating margin), whereas IRTC carries 54.9/100 (HOLD) at $90.59 (59.1x Forward P/E, 4.5% operating margin).
Composite vs. Pillar Nuance: While IRTC currently prints a higher short-term Unified Composite Score (54.9/100 HOLD vs. EHTH 40.8/100 SELL), EHTH captures the overall institutional head-to-head verdict (5–5 matrix metrics and 4–2 across the 6 pillars) due to superior fundamental profitability (11.9% vs. 4.5% operating margin) and revenue trajectory (-60.5% vs. +14.9% YoY).
Technical & Structure Timing Caution: EHTH is currently in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 24.9); meanwhile IRTC is in a short-term Weinstein Markdown pullback below its falling 50-day moving average and Breakdown options structure phase (RSI 34.6). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on EHTH vs IRTC. Trailing 12-month operating profitability (EHTH 11.9% vs IRTC 4.5%) and valuation multiples (EHTH 0.2x vs IRTC 59.1x Forward P/E) are benchmarked directly in Pillar 4 below.
Competes within the Medical Devices value chain with $3.1B market capitalization and 4.5% operating margin.
OpEx & R&D Reinvestment67.4% of Rev ($576M)
90D Engineering Disclosures0 Published
Investor FAQ EHTH vs IRTC Key Questions & Quantitative Answers
As of Nov 17, 2026, eHealth, Inc. (EHTH) is the stronger overall head-to-head candidate over iRhythm Technologies, Inc (IRTC) in the Tradestie Institutional Equity Comparison Engine, winning 5–5 core matrix metrics and 4–2 across our 6-pillar institutional scorecard (led by Valuation Multiples, Profitability & Quality, Balance Sheet & Cash Flow). EHTH carries a Unified Composite Score of 40.8/100 (SELL) at $0.35 (0.2x Forward P/E, 11.9% operating margin), whereas IRTC carries 54.9/100 (HOLD) at $90.59 (59.1x Forward P/E, 4.5% operating margin). Composite vs. Pillar Nuance: While IRTC currently prints a higher short-term Unified Composite Score (54.9/100 HOLD vs. EHTH 40.8/100 SELL), EHTH captures the overall institutional head-to-head verdict (5–5 matrix metrics and 4–2 across the 6 pillars) due to superior fundamental profitability (11.9% vs. 4.5% operating margin) and revenue trajectory (-60.5% vs. +14.9% YoY). Technical & Structure Timing Caution: EHTH is currently in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 24.9); meanwhile IRTC is in a short-term Weinstein Markdown pullback below its falling 50-day moving average and Breakdown options structure phase (RSI 34.6). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.
IRTC leads the Growth & Scale pillar: EHTH posts -60.5% YoY revenue growth and -17.6% YoY earnings growth on $469M TTM revenue (100.0% gross margin, 11.9% operating margin), compared with IRTC at +14.9% YoY revenue growth and +0.0% YoY earnings growth on $854M TTM revenue (71.9% gross margin, 4.5% operating margin). On trailing 12-month operating scale, EHTH generates $469M in USD-normalized revenue versus $854M for IRTC. In operating R&D and SG&A reinvestment, EHTH deploys N/A (0 90-day corporate R&D disclosures) versus 67.4% of Rev ($576M) (0 disclosures) for IRTC.
EHTH screens cheaper on headline valuation multiples. EHTH trades at 0.2x Forward P/E, 0.2x Trailing P/E, 0.72x PEG, and N/M EV/Revenue (12.4% EBITDA margin), whereas IRTC trades at 59.1x Forward P/E, 54.6x Trailing P/E, N/M PEG, and 4.0x EV/Revenue (0.9% FCF margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against EHTH (2.6% ROE) versus IRTC (-25.8% ROE) capital efficiency.
In options market volatility and institutional positioning, EHTH carries 128.7% implied volatility (56th %ile, Balanced (25th–60th %ile)), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (1.61β · 117% Vol realized risk). By comparison, IRTC carries 49.1% implied volatility (7th %ile, Compressed (<25th %ile)), a 1.19x (Put-Skewed) Put/Call open-interest ratio, DISTRIBUTION on-balance volume, and sits in a BREAKDOWN options structure phase (0.42β · 116% Vol realized risk).
Cross-Compare 1-Click Peer Rivalries & Single-Stock Research
Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 17, 2026. For educational research only; not investment advice.